(Q46625302)

English

The reduction of (ImH)[trans-RuIIICl4(dmso)(Im)] under physiological conditions: preferential reaction of the reduced complex with human serum albumin.

scientific article published on 26 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

The reduction of (ImH)[trans-RuIIICl4(dmso)(Im)] under physiological conditions: preferential reaction of the reduced complex with human serum albumin (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Andrzej Skoczowski

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Grażyna Stochel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

object named as

Iwona Stawoska

2

0 references

object named as

Rudi van Eldik

6

0 references

author name string

Malgorzata Brindell

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Justyna Supel

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

26 April 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Journal of Biological Inorganic Chemistry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

909-918

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18438690%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

https://scigraph.springernature.com/pub.10.1007/s00775-008-0378-3

0 references

Ascorbic acid: much more than just an antioxidant.

1 reference

https://api.crossref.org/works/10.1007%2FS00775-008-0378-3

21 January 2018

A kinetic study of the chemical stability of the antimetastatic ruthenium complex NAMI-A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A spectroscopic study of the reaction of NAMI, a novel ruthenium(III)anti-neoplastic complex, with bovine serum albumin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and anti

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of cisplatin and NAMI-A plasma-protein interactions in relation to combination therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological role of adduct formation of the ruthenium(III) complex NAMI-A with serum albumin and serum transferrin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Electrochemical measurements confirm the preferential bonding of the antimetastatic complex [ImH][RuCl(4)(DMSO)(Im)] (NAMI-A) with proteins and the weak interaction with nucleobases

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Interaction of the Antitumor Complexes Na[trans-RuCl(4) (DMSO)(Im)] and Na[trans-RuCl(4)(DMSO)(Ind)] With Apotransferrin: a Spectroscopic Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of Cis- and Trans-RuCl (2)(DMSO)(4) With Human Serum Albumin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A spectroscopic study of the haemin--human-serum-albumin system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Phase I and pharmacological study with imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a novel ruthenium anticancer agent.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bicyclic ring formation is not necessary for the (auto)oxidation of ascorbic acid

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Kinetics and mechanism of the reduction of (ImH)[trans-RuCl4(dmso)(Im)] by ascorbic acid in acidic aqueous solution

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Binding of Antitumor Ruthenium(III) Complexes to Plasma Proteins

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A theoretical study on the hydrolysis process of the antimetastatic ruthenium(III) complex NAMI-A

1 reference

https://pubmed.ncbi.nlm.nih.gov/18438690

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46625302&oldid=1717317921"